A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D. Ngoc et al., Catecholaminergic Polymorphic Ventricular Tachycardia in Children : A 7-Year Follow-up of 21 Patients, Circulation, vol.91, issue.5, pp.1512-1531, 1995.
DOI : 10.1161/01.CIR.91.5.1512

S. Priori, C. Napolitano, M. Memmi, B. Colombi, F. Drago et al., Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.106, issue.1, pp.69-74, 2002.
DOI : 10.1161/01.CIR.0000020013.73106.D8

B. Bauce, A. Rampazzo, C. Basso, A. Bagattin, L. Daliento et al., Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death, Journal of the American College of Cardiology, vol.40, issue.2, pp.341-350, 2002.
DOI : 10.1016/S0735-1097(02)01946-0

A. Postma, I. Denjoy, J. Kamblock, M. Alders, J. Lupoglazoff et al., Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients, Journal of Medical Genetics, vol.42, issue.11, pp.863-70, 2005.
DOI : 10.1136/jmg.2004.028993

M. Hayashi, I. Denjoy, F. Extramiana, A. Maltret, N. Buisson et al., Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.119, issue.18, pp.2426-2460, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.829267
URL : https://hal.archives-ouvertes.fr/inserm-00410301

P. Laitinen, K. Brown, K. Piippo, H. Swan, J. Devaney et al., Mutations of the Cardiac Ryanodine Receptor (RyR2) Gene in Familial Polymorphic Ventricular Tachycardia, Circulation, vol.103, issue.4, pp.485-90, 2001.
DOI : 10.1161/01.CIR.103.4.485

S. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati et al., Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation, vol.103, issue.2, pp.196-200, 2001.
DOI : 10.1161/01.CIR.103.2.196

H. Lahat, M. Eldar, E. Levy-nissenbaum, T. Bahan, E. Friedman et al., Autosomal Recessive Catecholamine- or Exercise-Induced Polymorphic Ventricular Tachycardia : Clinical Features and Assignment of the Disease Gene to Chromosome 1p13-21, Circulation, vol.103, issue.23, pp.2822-2829, 2001.
DOI : 10.1161/01.CIR.103.23.2822

A. Postma, I. Denjoy, T. Hoorntje, J. Lupoglazoff, D. Costa et al., Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia, Circulation Research, vol.91, issue.8, pp.21-27, 2002.
DOI : 10.1161/01.RES.0000038886.18992.6B

G. Choi, L. Kopplin, D. Tester, M. Will, C. Haglund et al., Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes, Circulation, vol.110, issue.15, pp.2119-2143, 2004.
DOI : 10.1161/01.CIR.0000144471.98080.CA

A. Krahn, J. Healey, V. Chauhan, D. Birnie, C. Simpson et al., Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER), Circulation, vol.120, issue.4, pp.278-85, 2009.
DOI : 10.1161/CIRCULATIONAHA.109.853143

D. Tester and M. Ackerman, Postmortem Long QT Syndrome Genetic Testing for Sudden Unexplained Death in the Young, Journal of the American College of Cardiology, vol.49, issue.2, pp.240-246, 2007.
DOI : 10.1016/j.jacc.2006.10.010

J. Svendsen and P. Geelen, Screening for, and management of, possible arrhythmogenic syndromes (channelopathies/ion channel diseases), Europace, vol.12, issue.5, pp.741-743, 2010.
DOI : 10.1093/europace/euq126

K. Haugaa, I. Leren, K. Berge, J. Bathen, J. Loennechen et al., High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening, Europace, vol.12, issue.3, pp.417-440, 2010.
DOI : 10.1093/europace/eup448

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-81, 1958.
DOI : 10.1214/aoms/1177731566

C. Van-der-werf, P. Kannankeril, F. Sacher, A. Krahn, S. Viskin et al., Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia, Journal of the American College of Cardiology, vol.57, issue.22, pp.2244-54, 2011.
DOI : 10.1016/j.jacc.2011.01.026

H. Swan, P. Laitinen, K. Kontula, and L. Toivonen, Calcium Channel Antagonism Reduces Exercise-Induced Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia Patients with RyR2 Mutations, Journal of Cardiovascular Electrophysiology, vol.193, issue.2, pp.162-168, 2005.
DOI : 10.1016/S0002-9149(96)00011-2

A. Wilde, Z. Bhuiyan, L. Crotti, M. Facchini, D. Ferrari et al., Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia, New England Journal of Medicine, vol.358, issue.19, pp.2024-2033, 2008.
DOI : 10.1056/NEJMoa0708006

M. Cerrone, B. Colombi, R. Bloise, M. Memmi, C. Moncalvo et al., Clinical and molecular characterization of a large cohort of patients affected with catecholaminergic polymorphic ventricular tachycardia, Circulation, vol.110, p.552, 2004.

H. Swan, K. Piippo, M. Viitasalo, P. Heikkila, T. Paavonen et al., Arrhythmic disorder mapped to chromosome 1q42???q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts, Journal of the American College of Cardiology, vol.34, issue.7, pp.2035-2077, 1999.
DOI : 10.1016/S0735-1097(99)00461-1

N. Sumitomo, K. Harada, M. Nagashima, T. Yasuda, Y. Nakamura et al., Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death, Heart, vol.89, issue.1, pp.66-70, 2003.
DOI : 10.1136/heart.89.1.66

R. Sy, M. Gollob, G. Klein, Y. R. Skanes, A. Gula et al., Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia, Heart Rhythm, vol.8, issue.6, pp.864-71, 2011.
DOI : 10.1016/j.hrthm.2011.01.048